Zydus Lifesciences informs about press release

23 Nov 2022 Evaluate

Zydus Lifesciences has informed that it enclosed a copy of press release dated November 23, 2022 titled ‘Zydus receives final approval from the USFDA for Famotidine Injection’.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

887.05 -18.95 (-2.09%)
16-Mar-2026 15:14 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1781.90
Dr. Reddys Lab 1275.65
Cipla 1300.00
Zydus Lifesciences 887.05
Lupin 2288.70
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×